The US Preventative Services Taskforce recommendation regarding prostate cancer screening
The US Preventative Services taskforce has now reversed its 2012 recommendation against prostate cancer screening in the 55-69 year age group based on new evidence from prostate cancer screening trials. This is welcome news for future prostate cancer patients and those at the frontline of fighting this disease. Is it time for the NHMRC to do the same?